Detalles de la búsqueda
1.
FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 26(11): 2165-2173, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717436
2.
Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
Transfusion
; 58(4): 1045-1053, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29446444
3.
Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure.
J Clin Apher
; 32(4): 224-234, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27578390
4.
Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease.
Blood
; 123(2): 290-9, 2014 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-24255916
5.
Umbilical Cord Blood Transplantation Is a Feasible Rescue Therapeutic Option for Patients Suffering from Graft Failure after Previous Hematopoietic Stem Cell Transplantation.
Oncology
; 90(3): 160-6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26871562
6.
Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation.
Croat Med J
; 57(3): 255-65, 2016 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27374827
7.
CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 21(2): 250-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25460358
8.
CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
Blood
; 121(10): 1886-95, 2013 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-23303823
9.
Allogeneic Hematopoietic Stem Cell Transplantation in Mantle Cell Lymphoma: A Retrospective Analysis of 7 Patients.
Oncology
; 89(2): 118-23, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25895548
10.
Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experience.
Oncology
; 89(4): 196-204, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26228581
11.
Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.
Eur J Haematol
; 95(1): 75-82, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25546348
12.
Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
BMC Infect Dis
; 15: 584, 2015 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26715563
13.
Clofarabine/cyclophosphamide for debulking before stem cell transplantation.
Eur J Clin Invest
; 44(8): 775-83, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24942362
14.
Fatal skin and pulmonary infection caused by Hormographiella aspergillata in a leukaemic patient: case report and literature overview.
Mycoses
; 56(6): 687-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23672484
15.
Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning.
Transfusion
; 52(6): 1348-53, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22128859
16.
Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.
Biol Blood Marrow Transplant
; 17(1): 133-40, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20601032
17.
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Transfusion
; 51(5): 968-75, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20880037
18.
A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001).
Front Med (Lausanne)
; 7: 634260, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33585521
19.
Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients.
NPJ Vaccines
; 5(1): 67, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728481
20.
Erratum: Author Correction: Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients.
NPJ Vaccines
; 5: 79, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32922963